The growth hormone response to hexarelin in children: Reproducibility and effect of sex steroids

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 3, 1997, Pages 861-864

  Loche, Sandro ^a   Colao, Annamaria ^b   Cappa, Marco ^c   Bellone, Jaele ^d   Aimaretti, Gianluca ^d   Farello, Giovanni ^e   Faedda, Antonella ^a   Lombardi, Gaetano ^b   Deghenghi, Romano ^f   Ghigo, Ezio ^d  

^a Osp Regionale per le Microcitemie   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

^e UNIVERSITY OF L'AQUILA   (Italy)

^f Ardana   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ETHINYLESTRADIOL; GROWTH HORMONE; HEXARELIN; OXANDROLONE; SEX HORMONE; TESTOSTERONE;

ADOLESCENT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; REPRODUCIBILITY; SCHOOL CHILD; SHORT STATURE;

ADOLESCENT; BODY HEIGHT; CHILD; ETHINYL ESTRADIOL; FEMALE; HUMAN GROWTH HORMONE; HUMANS; MALE; OLIGOPEPTIDES; OXANDROLONE; REPRODUCIBILITY OF RESULTS; TESTOSTERONE;

EID: 8044230701     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.3.861     Document Type: Article

References (32)

1. Kerrigan JR, Rogol AD. 1992 The impact of gonadal steroid hormone action on growth hormone secretion during childhood and adolescence. Endocr Rev. 13:281-298.
2. Marin G, Domene HM, Barnes KM, et al. 1994 The effect of estrogen priming and puberty on the growth hormone response to standardized treadmill exercise and arginine-insulin in normal girls and boys. J Clin Endocrinol Metab 79:537-541.
3. Martin L, Clark J, Conner T. 1968 Growth hormone secretion enhanced by androgens. J Clin Endocrinol Metab. 28:425-428.
4. Gourmelen M, Pham-Huu-Trung M, Girard F. 1979 Transient partial hGH deficiency in prepubertal children with delay of growth. Pediatr Res 13:221-224.
5. Liu L, Merriam GR, Sherins RJ. 1987 Chronic sex steroid exposure increases mean plasma growthhormone concentration and pulse amplitude in men with isolated hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 64:651-656.
6. Weissberger AJ, Ho KKY. 1993 Activation of the somatotropic axis by testosterone in adult males: evidence for the role of aromatization. J Clin Endocrinol Metab. 76:1407-1412.
7. Malhotra A, Poon E, Tse WY, et al. 1993 The effects of oxandrolone on the growth hormone and gonadal axes in boys with constitutional delay of growth and puberty. Clin Endocrinol (Oxf). 38:393-398.
8. Link K, Blizzard RM, Evans WS, Kaiser DL, Parker MW, Rogol AD. 1986 The effect of androgens on the pulsatile release and the twenty four hour mean concentration of growth hormone in peripubertal males. J Clin Endocrinol Metab. 52:159-164.
9. Keenan BS, Richards GE, Ponder SW. 1993 Androgen-stimulated pubertal growth: the effects of testosterone, and dihydrotestosterone on growth hormone and insulin-like growth factor-I in the treatment of short stature and delayed puberty. J Clin Endocrinol Metab. 76:996-1001.
10. Eakman GD, Dallas JS, Ponder SW, Keenan BS. 1996 The effects of testosterone and dihydrotestosterone on hypothalamic regulation of growth hormone secretion. J Clin Endocrinol Metab. 81:1217-1223.
11. Metzger DL, Kerrigan JR. 1994 Estrogen receptor blockade with tamoxifen diminishes growth hormone secretion in boys: evidence for a stimulatory role of endogenous estrogens during male adolescence. J Clin Endocrinol Metab. 79:513-518.
12. Deghenghi R, Cananzi MM, Torsello A, Battisti C, MÜller EE, Locatelli V. 1994 GH-releasing activity of hexarelin, a new growth hormone releasing peptide, in infant, and adult rats. Life Sci. 54:1321-1328.
13. Ghigo E, Arvat E, Gianotti L, et al. 1994 GH-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal and oral administration in man. J Clin Endocrinol Metab. 78:693-698.
14. Imbimbo BP, Mont T, Edwards M, et al. 1994 Growth hormone releasing activity of hexarelin in humans: a dose response study. Eur J Clin Pharmacol. 46:421-425.
15. Loche S, Cambiaso P, Carta D, et al. 1995 The growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, in short normal and obese children, and in hypopiruitary subjects. J Clin Endocrinol Metab. 80:674-678.
16. Bellone J, Aimaietti G, Bartolotta E, et al. 1995 Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, before and during puberty. J Clin Endocrinol Metab. 80:1090-1094.
17. Tassoni P, Cacciari M, Cau M, et al. 1990 Variability of growth hormone response to pharmacological and sleep tests performed twice in short children. J Clin Endocrinol Metab. 71:230-234.
18. Mazza E, Ghigo E, Goffi S, et al. 1989 Effect of the potentiation of cholinergic activity on the variability in individual GH response to GH-releasing hormone. J Endocrinol Invest. 12:795-798.
19. Ghigo E, Bellone J, Aimaretti J, et al. 1996 Reliability of provocative tests to assess GH secretory status. Study in 472 normally growing children. J Clin Endocrinol Metab. 81:3323-3327.
20. Devesa J, Lima L, Lois N, Lechjga MJ, Arce V, Tresguerres JAF. 19H9 Reasons for the variability in the growth hormone (CH) responses to GHRH challenge: the endogenous hypothalamic-somatotroph rhythm (HSR). Clin Endocrinol (Oxf). 30:367-377.
21. Arvat E, Gianotti L, Di Vito L, et al. 1995 Modulation of growth hormonereleasing activity of hexarelin in man. Neuroendocrinology. 61:51-56.
22. Maccario M, Arvat E, Procopio M, et al. 1995 Metabolic modulation of the growth hormone-releasing activity of hexarelin in man. Metabolism. 44:134-138.
23. Cappa M, Setzu S, Bernaidini S, et al. 1995 Exogenous GH administration does not inhibit the GH response to hexarelin in normal men. J Endocrinol Invest. 18:762-766.
24. 2 in the rat. Endocrinology. 117:1441-1447.
25. Bowers CY, Sartor AO, Reynolds GA, Badger TM. 1991 On the actions of the growth hormone-releasing hexapeptide, GHRP. Endocrinology. 128: 2027-2035.
26. Fletcher TP, Thomas GB, Willoughby JO, Clarke IJ. 1994 Constitutive growth hormone secretion in sheep after hypothalamopituitary disconnection and the direct in vivo pituitary effect of growth hormone releasing peptide 6. Neuroendocrinology. 60:76-86.
27. Popovic V, Damjanovic S, Micic D, Djurovic M, Dieguez, C, Casanueva FF. 1995 Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP-6 main action is exerted at the hypothalamic level. J Clin Endocrinol Metab. 80:942-947.
28. Loche S, Cambiaso P, Merola B, et al. 1995 The effect of hexarelin on growth hormone (GH) secretion in patients with GH deficiency. J Clin Endocrinol Metab. 80:2692-2696.
29. 2 on growth hormone (GH)-releasing factor-stimulated GH release and intracellular adenosine 3′,5′-monophosphate accumulation in rat primary pituitary cell culture. Endocrinology. 124:2791-2798.
30. Bowers CY, Reynolds GA, Durham D, Barrera CM, Pezzoli SS, Thorner MO. 1990 Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone. J Clin Endocrinol Metab, 70:975-982.
31. Van der Ploeg LHT, Howard AD, Feighner SD, et al. Cloning of a G-protein coupled receptor for the growth hormone releasing peptide (GHRP-6) and non-peptidyl growth hormone secretagogues [Abstract p 119]. Proc of the 10th International Congress of Endocrinology. 1996; 119.
32. Cappa M, Salvatori R, Loche S, et al. 1991 The growth hormone response to pyridostigmine plus growth hormone releasing hormone is not influenced by pubertal maturation. J Endocrinol Invest. 14:41-45.